SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001590750-20-000082
Filing Date
2020-08-05
Accepted
2020-08-05 17:08:14
Documents
66
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgen-20200630.htm   iXBRL 10-Q 1864759
2 EX-31.1 mgen-q22020xex311.htm EX-31.1 14194
3 EX-31.2 mgen-q22020xex312.htm EX-31.2 15547
4 EX-32.1 mgen-q22020xex321.htm EX-32.1 14373
  Complete submission text file 0001590750-20-000082.txt   7337869

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgen-20200630.xsd EX-101.SCH 41675
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgen-20200630_cal.xml EX-101.CAL 62652
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgen-20200630_def.xml EX-101.DEF 230641
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgen-20200630_lab.xml EX-101.LAB 563299
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgen-20200630_pre.xml EX-101.PRE 358523
10 EXTRACTED XBRL INSTANCE DOCUMENT mgen-20200630_htm.xml XML 1173409
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36483 | Film No.: 201078513
SIC: 8071 Services-Medical Laboratories